Ocugen announces FDA alignment for Phase 2/3 trial of gene therapy OCU410ST for Stargardt disease, showing promising initial results. Ocugen, Inc. announced it has received FDA approval to proceed ...
Luci indicated the company is focused on securing additional funding opportunities to support the Phase 3 ibezapolstat clinical trial program and expects further updates on funding initiatives in ...
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
– End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – – Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 – – ...
The Austin Transit Partnership (ATP) on May 23 recommended a 9.8-mile, 15-station light rail alignment as the first phase of Project Connect, based on the expertise of partners ATP, the city of Austin ...
A "selfie" taken by the James Webb Space telescope during the early stages of calibration process. NASA SHARE Focusing a six-ton, $10 billion space telescope isn’t as simple as turning the focus ring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback